Ardelyx, Inc. (ARDX)
USD 4.59
(-3.27%)
USD 4.59
(-3.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 51.54 Million USD | 780.39% |
| 2022 | 5.85 Million USD | -39.94% |
| 2021 | 9.74 Million USD | -79.27% |
| 2020 | 47.03 Million USD | -7.61% |
| 2019 | 50.9 Million USD | 3.45% |
| 2018 | 49.2 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 101.92 Million USD | 0.46% |
| 2024 Q2 | 100.24 Million USD | 0.42% |
| 2024 Q1 | 99.83 Million USD | 100.38% |
| 2023 Q2 | 3.75 Million USD | -22.06% |
| 2023 Q4 | 51.54 Million USD | 71.16% |
| 2023 FY | 51.54 Million USD | 780.39% |
| 2023 Q1 | 4.81 Million USD | -17.78% |
| 2023 Q3 | 30.11 Million USD | 702.67% |
| 2022 Q3 | 6.87 Million USD | -12.46% |
| 2022 Q2 | 7.85 Million USD | -10.84% |
| 2022 Q1 | 8.81 Million USD | -9.6% |
| 2022 FY | 5.85 Million USD | -39.94% |
| 2022 Q4 | 5.85 Million USD | -14.87% |
| 2021 Q3 | 17.7 Million USD | -33.66% |
| 2021 Q4 | 9.74 Million USD | -44.93% |
| 2021 FY | 9.74 Million USD | -79.27% |
| 2021 Q1 | 34.74 Million USD | -26.13% |
| 2021 Q2 | 26.68 Million USD | -23.21% |
| 2020 Q4 | 47.03 Million USD | -7.2% |
| 2020 Q1 | 44.14 Million USD | -13.28% |
| 2020 FY | 47.03 Million USD | -7.61% |
| 2020 Q2 | 37.34 Million USD | -15.41% |
| 2020 Q3 | 50.68 Million USD | 35.72% |
| 2019 Q1 | 53.46 Million USD | 8.65% |
| 2019 FY | 50.9 Million USD | 3.45% |
| 2019 Q4 | 50.9 Million USD | -3.17% |
| 2019 Q3 | 52.57 Million USD | -0.86% |
| 2019 Q2 | 53.03 Million USD | -0.82% |
| 2018 Q2 | 48.83 Million USD | 0.0% |
| 2018 FY | 49.2 Million USD | 0.0% |
| 2018 Q3 | 49.02 Million USD | 0.38% |
| 2018 Q4 | 49.2 Million USD | 0.39% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | 27.625% |
| Alkermes plc | 287.73 Million USD | 82.085% |
| Agenus Inc. | 137.32 Million USD | 62.463% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 97.8% |
| Aptorum Group Limited | 3.05 Million USD | -1585.369% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | 50.724% |
| Bicycle Therapeutics plc | 40.08 Million USD | -28.61% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | 48.759% |
| ChromaDex Corporation | 2.57 Million USD | -1901.825% |
| Chimerix, Inc. | 125 Thousand USD | -41137.6% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -1491.629% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -98.962% |
| CRISPR Therapeutics AG | 223 Million USD | 76.885% |
| Precision BioSciences, Inc. | 7.72 Million USD | -567.448% |
| Dyadic International, Inc. | 88.87 Thousand USD | -57902.701% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -234204.545% |
| Fortress Biotech, Inc. | 60.85 Million USD | 15.297% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -83721.712% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -1256.143% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -57095.642% |
| Incyte Corporation | 29.16 Million USD | -76.761% |
| IO Biotech, Inc. | 1.83 Million USD | -2702.991% |
| Jaguar Health, Inc. | 30.99 Million USD | -66.318% |
| Novavax, Inc. | 168.01 Million USD | 69.32% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -123.874% |
| Opthea Limited | 200.53 Million USD | 74.295% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -795.691% |
| ContextLogic Inc. | 6 Million USD | -759.117% |
| MiMedx Group, Inc. | 48.09 Million USD | -7.169% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -156.465% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -134519.101% |
| NextCure, Inc. | 5.94 Million USD | -766.482% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -35449.655% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -133.128% |
| PDS Biotechnology Corporation | 19.5 Million USD | -164.26% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | 55.363% |
| Pharming Group N.V. | 166.1 Million USD | 68.967% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -729.664% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -53.803% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -4174.212% |
| Acelyrin, Inc. | 1.19 Million USD | -4217.169% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -11105.87% |
| Summit Therapeutics Inc. | 103.29 Million USD | 50.095% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -1267.657% |
| Senti Biosciences, Inc. | 33.53 Million USD | -53.697% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -979.971% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -49.169% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | 14.546% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -3183.248% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -102.909% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | 50.596% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -6941.94% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -360.611% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 62.729% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -283.563% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -243.647% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 73.002% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | 2.11% |
| Fortress Biotech, Inc. | 60.85 Million USD | 15.297% |
| Precigen, Inc. | 5.89 Million USD | -774.419% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -22.766% |
| AlloVir, Inc. | 16.64 Million USD | -209.629% |
| C4 Therapeutics, Inc. | 65.75 Million USD | 21.61% |
| Fate Therapeutics, Inc. | 97.36 Million USD | 47.055% |
| ImmuCell Corporation | 10.54 Million USD | -389.038% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -4481.956% |
| Onconetix, Inc. | 118.85 Thousand USD | -43268.922% |
| PureTech Health plc | 18.25 Million USD | -182.449% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -51967.677% |
| Elevation Oncology, Inc. | 30.13 Million USD | -71.042% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -98.533% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -20.229% |
| Innoviva, Inc. | 446.23 Million USD | 88.448% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -6088.115% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -77015.373% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 75.094% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | 27.598% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -1516.907% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -4865.992% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -130.883% |
| Aptose Biosciences Inc. | 621 Thousand USD | -8200.644% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -4998.948% |
| Century Therapeutics, Inc. | 46.65 Million USD | -10.478% |
| Kura Oncology, Inc. | 9.33 Million USD | -452.368% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -93.06% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -37252.899% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -449.249% |
| Autolus Therapeutics plc | 47.91 Million USD | -7.582% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -950.693% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -661.066% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | 60.549% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -535.99% |
| IGM Biosciences, Inc. | 34.67 Million USD | -48.67% |
| INmune Bio, Inc. | 397 Thousand USD | -12884.131% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 70.333% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -1171.428% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -34978.156% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -3.566% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | 5.54% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -12.812% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 89.111% |
| Verastem, Inc. | 40.08 Million USD | -28.591% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -1070.99% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -412.701% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -685.658% |
| Histogen Inc. | 4.38 Million USD | -1075.798% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -5744.331% |
| Organovo Holdings, Inc. | 888 Thousand USD | -5704.842% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -71.823% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -1129.065% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -172.808% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | 31.906% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -55264.968% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -98.969% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -19205.993% |
| Amarin Corporation plc | 8.73 Million USD | -489.985% |
| Mesoblast Limited | 100.48 Million USD | 48.701% |
| Turnstone Biologics Corp. | 1.18 Million USD | -4235.324% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | 34.192% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -47190.826% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | 37.145% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 72.862% |
| Better Therapeutics, Inc. | 10.34 Million USD | -398.135% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -122.906% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | 44.593% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -3889.706% |
| Gritstone bio, Inc. | 40.14 Million USD | -28.405% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -2741.621% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 66.439% |
| Insmed Incorporated | 1.19 Billion USD | 95.68% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -711.764% |
| OmniAb, Inc. | 22.07 Million USD | -133.508% |
| Alector, Inc. | 30.45 Million USD | -69.251% |
| Seres Therapeutics, Inc. | 101.54 Million USD | 49.237% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -540.574% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 87.917% |
| Aura Biosciences, Inc. | 16.87 Million USD | -205.554% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | 9.398% |
| Immunic, Inc. | 639 Thousand USD | -7966.823% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -72.866% |
| Veracyte, Inc. | 7.52 Million USD | -585.01% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 92.007% |
| FibroGen, Inc. | 89.69 Million USD | 42.532% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -1088.54% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -39290.049% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 98.991% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -139216.216% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -2503.384% |
| TG Therapeutics, Inc. | 100.11 Million USD | 48.514% |
| Galecto, Inc. | 66 Thousand USD | -78001.515% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -37802.206% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 96.842% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -756.974% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -855.105% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -2741.621% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -140.346% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -41.012% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -9870.406% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -13.951% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -68.598% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -15.055% |
| Vaxxinity, Inc. | 13.26 Million USD | -288.682% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 93.646% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -11379.046% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -486.494% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 98.093% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -16212.342% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -1056.281% |
| Ainos, Inc. | 5.92 Million USD | -770.498% |
| Pluri Inc. | 29.05 Million USD | -77.424% |
| Prothena Corporation plc | 10.72 Million USD | -380.804% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -159.67% |
| Celularity Inc. | 26.17 Million USD | -96.917% |
| Rallybio Corporation | 173 Thousand USD | -29695.954% |
| Cue Biopharma, Inc. | 4.2 Million USD | -1126.725% |
| MeiraGTx Holdings plc | 72.11 Million USD | 28.525% |
| Omeros Corporation | 329.7 Million USD | 84.366% |
| Humacyte, Inc. | 38.6 Million USD | -33.541% |
| Immunocore Holdings plc | 82.64 Million USD | 37.628% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -3095.722% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -1341.068% |
| Blueprint Medicines Corporation | 610.96 Million USD | 91.563% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -3435.46% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | 45.848% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -5.881% |
| Sana Biotechnology, Inc. | 90.9 Million USD | 43.293% |
| Pulmatrix, Inc. | 8.32 Million USD | -519.034% |
| Elicio Therapeutics, Inc. | 6 Million USD | -758.116% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -298.2% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | 46.72% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -10890.832% |
| Cytokinetics, Incorporated | 607.37 Million USD | 91.513% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -493.04% |
| Nutriband Inc. | 79.82 Thousand USD | -64474.199% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -1049.576% |
| Vor Biopharma Inc. | 31.83 Million USD | -61.945% |
| Roivant Sciences Ltd. | 477.85 Million USD | 89.213% |
| Evogene Ltd. | 10.65 Million USD | -383.873% |
| ProKidney Corp. | 3.61 Million USD | -1327.895% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -6691.436% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -195702.629% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 97.03% |
| CorMedix Inc. | 517.01 Thousand USD | -9870.155% |
| BioLineRx Ltd. | 6.62 Million USD | -677.716% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -39.929% |
| Galectin Therapeutics Inc. | 71.74 Million USD | 28.148% |
| Atai Life Sciences N.V. | 15.21 Million USD | -238.88% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -6019.144% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -20114.51% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -19.46% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -12452.233% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -3665.303% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -7673.651% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 71.052% |
| Biomea Fusion, Inc. | 7.83 Million USD | -558.327% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 81.863% |
| Mereo BioPharma Group plc | 5.3 Million USD | -872.585% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -2297.535% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -8666.497% |
| Absci Corporation | 4.66 Million USD | -1006.159% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -347.379% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -127.129% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -415.212% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -348.04% |
| Allakos Inc. | 38.21 Million USD | -34.887% |
| Imunon, Inc. | 1.13 Million USD | -4424.473% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -497.369% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -6065.909% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -515370.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | 41.653% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -994.649% |
| XOMA Corporation | 118.51 Million USD | 56.507% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -411.938% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -39.019% |
| aTyr Pharma, Inc. | 13.76 Million USD | -274.424% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -552.576% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -106.485% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -155.12% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -343546.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -18429.422% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -256.607% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 96.562% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -37754.053% |
| UroGen Pharma Ltd. | 98.55 Million USD | 47.695% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 65.431% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -170.347% |
| Entera Bio Ltd. | 256 Thousand USD | -20035.547% |
| GH Research PLC | 631 Thousand USD | -8069.097% |
| Lisata Therapeutics, Inc. | 137.00 USD | -37625447.445% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -7929.128% |
| Xencor, Inc. | 14.64 Million USD | -252.049% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -34207.259% |
| Replimune Group, Inc. | 71.99 Million USD | 28.397% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -34264.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -635.755% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -37754.053% |
| Portage Biotech Inc. | 7000.00 USD | -736285.714% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -7673.651% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -3507.208% |
| OncoCyte Corporation | 2.2 Million USD | -2238.793% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -76945.064% |
| Purple Biotech Ltd. | 163 Thousand USD | -31523.926% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -1933.412% |
| scPharmaceuticals Inc. | 38.81 Million USD | -32.815% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -104.195% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -70512.329% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -2681.813% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -95.639% |
| Curis, Inc. | 1.48 Million USD | -3361.854% |
| Daré Bioscience, Inc. | 3.91 Million USD | -1217.099% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -7287.974% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -859016.667% |
| BeiGene, Ltd. | 197.61 Million USD | 73.916% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -5555.184% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | 36.026% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | 0.659% |
| bluebird bio, Inc. | 224.41 Million USD | 77.031% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 91.309% |
| DBV Technologies S.A. | 4.52 Million USD | -1038.909% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -3746.791% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -429.121% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -1268.383% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 86.337% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -20.221% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -2902.155% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -5454.634% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -195.111% |
| MacroGenics, Inc. | 30.19 Million USD | -70.708% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -191.177% |
| Prime Medicine, Inc. | 4.35 Million USD | -1083.085% |
| Aditxt, Inc. | 1.04 Million USD | -4848.145% |
| Adagene Inc. | 13.54 Million USD | -280.701% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -275.242% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 90.062% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -201.568% |
| SciSparc Ltd. | 24 Thousand USD | -214679.167% |
| Vericel Corporation | 81.85 Million USD | 37.027% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | 37.151% |
| Generation Bio Co. | 89.77 Million USD | 42.581% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -132.351% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 74.456% |
| Invivyd, Inc. | 722 Thousand USD | -7039.474% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -6.278% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -1762956.096% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -1247.634% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -224017.391% |
| 2seventy bio, Inc. | 244.01 Million USD | 78.875% |
| ADMA Biologics, Inc. | 130.59 Million USD | 60.529% |
| Clene Inc. | 7.15 Million USD | -620.735% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -1426.749% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 79.183% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -4581.835% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -19509.686% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 73.239% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -81.484% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -434.775% |
| Vir Biotechnology, Inc. | 111.67 Million USD | 53.841% |
| Evaxion Biotech A/S | 8.48 Million USD | -507.239% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | 31.202% |
| Verve Therapeutics, Inc. | 64.71 Million USD | 20.348% |
| Trevena, Inc. | 35.23 Million USD | -46.303% |
| Surrozen, Inc. | 882 Thousand USD | -5744.331% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -729.263% |
| Cingulate Inc. | 135.09 Thousand USD | -38054.983% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -118.986% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -7.839% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -28537.222% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -103.109% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -195.619% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -5407.158% |
| Statera Biopharma, Inc. | 11.43 Million USD | -350.935% |
| ImmunityBio, Inc. | 836.95 Million USD | 93.841% |
| Korro Bio, Inc. | 31.21 Million USD | -65.13% |
| Kineta, Inc. | 150 Thousand USD | -34264.667% |
| BioVie Inc. | 349.89 Thousand USD | -14632.176% |
| Codexis, Inc. | 12.24 Million USD | -321.032% |
| Celularity Inc. | 26.17 Million USD | -96.917% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -8.394% |
| Celcuity Inc. | 37.03 Million USD | -39.183% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -29130.769% |
| Cibus, Inc. | 17.67 Million USD | -191.654% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -1425.511% |
| Kodiak Sciences Inc. | 100 Million USD | 48.453% |
| Annexon, Inc. | 29.19 Million USD | -76.591% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | 20.239% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -4494.207% |
| Avalo Therapeutics, Inc. | 2 Million USD | -2477.35% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 96.319% |
| Eyenovia, Inc. | 8.95 Million USD | -475.479% |
| Puma Biotechnology, Inc. | 65.65 Million USD | 21.493% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -533.1% |
| Arcellx, Inc. | 50.84 Million USD | -1.389% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -3435.46% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -142.711% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -4785.972% |
| Moolec Science SA | 99.04 Thousand USD | -51943.495% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -86.622% |
| Geron Corporation | 35.05 Million USD | -47.063% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -8621.997% |
| Royalty Pharma plc | 6.13 Billion USD | 99.16% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -3039.281% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -162293.674% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -122.684% |
| Humacyte, Inc. | 38.6 Million USD | -33.541% |
| Structure Therapeutics Inc. | 4.01 Million USD | -1184.5% |
| 89bio, Inc. | 24.79 Million USD | -107.893% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -314.565% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -2662.433% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -4894.864% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | 48.198% |
| Notable Labs, Ltd. | 1.52 Million USD | -3277.916% |
| Liquidia Corporation | 2.36 Million USD | -2080.499% |
| Mustang Bio, Inc. | 1.97 Million USD | -2506.016% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -275.242% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -641.363% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -16160.883% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -3.348% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -436.724% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -78610.929% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -37802.206% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -722.909% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -39551.538% |
| PepGen Inc. | 17.1 Million USD | -201.444% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -10774.895% |
| United Therapeutics Corporation | 300 Million USD | 82.818% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -115.308% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -1138.262% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -8818.166% |
| XOMA Corporation | 118.51 Million USD | 56.507% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -139216.216% |
| Bionomics Limited | 117.62 Million USD | 56.178% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -5424.866% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -818.841% |
| uniQure N.V. | 130.06 Million USD | 60.368% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | 12.021% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -7414.14% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -1088.54% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -3621.805% |
| Altimmune, Inc. | 175 Thousand USD | -29355.429% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 86.71% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -818.841% |
| Compugen Ltd. | 719 Thousand USD | -7069.263% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -917.509% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | 39.037% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -419.104% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -708.073% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | 43.609% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -419.104% |
| Instil Bio, Inc. | 81.42 Million USD | 36.695% |
| argenx SE | 15.35 Million USD | -235.724% |
| Immunome, Inc. | 1.34 Million USD | -3746.791% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -9516.978% |
| Verona Pharma plc | 48.37 Million USD | -6.559% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -459.321% |
| Shattuck Labs, Inc. | 3.4 Million USD | -1413.417% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -60543.529% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -30582.738% |
| Moolec Science SA | 99.04 Thousand USD | -51943.495% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -367.247% |
| AnaptysBio, Inc. | 16.03 Million USD | -221.425% |
| Design Therapeutics, Inc. | 2.33 Million USD | -2108.526% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -190314.096% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -759.117% |
| Achilles Therapeutics plc | 1.07 Million USD | -4690.613% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -459.321% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -258462.4% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -207.882% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -64474.199% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -690785.94% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -396415.385% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 84.949% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -110.533% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -1961.888% |
| Palisade Bio, Inc. | 90 Thousand USD | -57174.444% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -26470.619% |
| Beam Therapeutics Inc. | 159.91 Million USD | 67.765% |
| Neurogene Inc. | 13.37 Million USD | -285.456% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 83.178% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -96.272% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -86067.296% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -5054.7% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -27.251% |
| Athira Pharma, Inc. | 1.21 Million USD | -4135.579% |
| Vaccinex, Inc. | 26 Thousand USD | -198157.692% |
| HCW Biologics Inc. | 6.3 Million USD | -717.646% |
| XOMA Corporation | 118.51 Million USD | 56.507% |
| Nektar Therapeutics | 112.62 Million USD | 54.231% |
| Arvinas, Inc. | 800 Thousand USD | -6343.375% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -256.607% |
| Merus N.V. | 10.48 Million USD | -391.486% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -246.302% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -283.848% |
| Rezolute, Inc. | 1.66 Million USD | -3005.241% |
| Clene Inc. | 7.15 Million USD | -620.735% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -70177.308% |
| BeyondSpring Inc. | 3.36 Million USD | -1432.313% |
| Synlogic, Inc. | 12.49 Million USD | -312.673% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -57.848% |
| Krystal Biotech, Inc. | 6.62 Million USD | -678.656% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 69.841% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -759.69% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -108715.52% |
| MannKind Corporation | 252.15 Million USD | 79.557% |
| Ikena Oncology, Inc. | 7.18 Million USD | -617.925% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -25803.015% |
| Gossamer Bio, Inc. | 197.4 Million USD | 73.888% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -9812.885% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 81.677% |
| Mural Oncology plc | 8.91 Million USD | -478.465% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -17.859% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -3489.624% |
| Champions Oncology, Inc. | 6.09 Million USD | -746.004% |
| REGENXBIO Inc. | 82.22 Million USD | 37.308% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -10334.552% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -1062.539% |
| Vaxart, Inc. | 2.62 Million USD | -1865.193% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -18876.847% |
| Cellectis S.A. | 36.24 Million USD | -42.234% |
| Longeveron Inc. | 1.44 Million USD | -3459.876% |
| Repare Therapeutics Inc. | 1.01 Million USD | -5003.663% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 95.448% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -15.14% |
| Revolution Medicines, Inc. | 80.57 Million USD | 36.026% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -1506.827% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -29022.599% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -41808.13% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 92.887% |
| Denali Therapeutics Inc. | 44.98 Million USD | -14.597% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -312.236% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -38054.983% |
| Passage Bio, Inc. | 22.92 Million USD | -124.89% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -753.568% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -7867.079% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -155.626% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -10419.796% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -12550.905% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -4238.973% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -10961.588% |
| OmniAb, Inc. | 22.07 Million USD | -133.508% |
| Anew Medical, Inc. | 1.54 Million USD | -3247.208% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -74.381% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -470.652% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -65.799% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -1171.428% |
| G1 Therapeutics, Inc. | 51.55 Million USD | 0.019% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -709.596% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -264.831% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -7570.685% |
| Alumis Inc. Common Stock | 30.86 Million USD | -67.035% |
| Equillium, Inc. | 384 Thousand USD | -13323.698% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -736.938% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 65.874% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -5.458% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -42747.999% |
| Dominari Holdings Inc. | 3.02 Million USD | -1602.345% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -260593.875% |
| vTv Therapeutics Inc. | 169 Thousand USD | -30401.183% |
| Bio-Techne Corporation | 319 Million USD | 83.841% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | 9.548% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 71.133% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -234.569% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -316.272% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -972.332% |
| Nkarta, Inc. | 82.27 Million USD | 37.344% |
| BioCardia, Inc. | 982 Thousand USD | -5149.185% |
| Iterum Therapeutics plc | 18.95 Million USD | -171.93% |